Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 9, 2015, Pages 387.e17-387.e27

  Choudhary, Dharamainder ^a   Hegde, Poornima ^a   Voznesensky, Olga ^a   Choudhary, Shilpa ^a   Kopsiaftis, Stavros ^a   Claffey, Kevin P ^a   Pilbeam, Carol C ^a   Taylor, John A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Bladder cancer; Lymph node; Metastasis; Oncomine

Indexed keywords

L SELECTIN; TRANSCRIPTOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER CELL LINE; BLOOD SAMPLING; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CELL VIABILITY; CLINICAL ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DATA BASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; LYMPH NODE METASTASIS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUSCLE INVASIVE BLADDER CANCER; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; RISK ASSESSMENT; RNA ISOLATION; TUMOR CELL; UPREGULATION; BIOSYNTHESIS; BLADDER TUMOR; METASTASIS; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

BIOMARKERS, TUMOR; CARCINOMA, TRANSITIONAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; L-SELECTIN; LASER CAPTURE MICRODISSECTION; MALE; NEOPLASM GRADING; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; TRANSCRIPTOME; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 84940467221     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.12.009     Document Type: Article

References (34)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society; 2014.
2. Herr H.W., Donat S.M. Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy. J Urol 2001, 165:62-64. [discussion 4].
3. Ries LAG, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, Mariotto A, et al. editors. SEER Cancer Statistics Review, 1975-2005. National Cancer Institute. Bethesda, MD, 2008; based on November 2007 SEER data submission, posted to the SEER web site. http://seer.cancer.gov/csr/1975_2005/.
4. Watts K.L., Ristau B.T., Yamase H.T., Taylor J.A. Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?. BJU Int 2011, 108:484-492.
5. McEver R.P. Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J 1997, 14:585-591.
6. Rosen S.D. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 2004, 22:129-156.
7. Michie S.A., Streeter P.R., Bolt P.A., Butcher E.C., Picker L.J. The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993, 143:1688-1698.
8. Arbones M.L., Ord D.C., Ley K., Ratech H., Maynard-Curry C., Otten G., et al. Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1994, 1:247-260.
9. Tedder T.F., Steeber D.A., Pizcueta P. L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995, 181:2259-2264.
10. Belanger S.D., St-Pierre Y. Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma. Blood 2005, 105:4800-4806.
11. Qian F., Hanahan D., Weissman I.L. L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci U S A 2001, 98:3976-3981.
12. Petzoldt J.L., Leigh I.M., Duffy P.G., Sexton C., Masters J.R. Immortalisation of human urothelial cells. Urol Res 1995, 23:377-380.
13. Rossi M.R., Masters J.R., Park S., Todd J.H., Garrett S.H., Sens M.A., et al. The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect 2001, 109:801-808.
14. Schleiffenbaum B., Spertini O., Tedder T.F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol 1992, 119:229-238.
15. Spertini O., Callegari P., Cordey A.S., Hauert J., Joggi J., von Fliedner V., et al. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 1994, 84:1249-1256.
16. Taylor J.A., Kuchel G.A., Hegde P., Voznesensky O.S., Claffey K., Tsimikas J., et al. Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer 2007, 7:135.
17. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
18. DeGraff D.J., Robinson V.L., Shah J.B., Brandt W.D., Sonpavde G., Kang Y., et al. Current preclinical models for the advancement of translational bladder cancer research. Mol Cancer Ther 2013, 12:121-130.
19. Smalley D.M., Ley K. L-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 2005, 9:255-266.
20. Yang S., Liu F., Wang Q.J., Rosenberg S.A., Morgan R.A. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. PLoS One 2011, 6:e22560.
21. Extermann M., Bacchi M., Monai N., Fopp M., Fey M., Tichelli A., et al. Relationship between cleaved L-selectin levels and the outcome of acute myeloid leukemia. Blood 1998, 92:3115-3122.
22. Dyrskjot L., Thykjaer T., Kruhoffer M., Jensen J.L., Marcussen N., Hamilton-Dutoit S., et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 2003, 33:90-96.
23. Modlich O., Prisack H.B., Pitschke G., Ramp U., Ackermann R., Bojar H., et al. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles. Clin Cancer Res 2004, 10:3410-3421.
24. Stransky N., Vallot C., Reyal F., Bernard-Pierrot I., de Medina S.G., Segraves R., et al. Regional copy number-independent deregulation of transcription in cancer. Nat Genet 2006, 38:1386-1396.
25. Blaveri E., Simko J.P., Korkola J.E., Brewer J.L., Baehner F., Mehta K., et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005, 11:4044-4055.
26. Dyrskjot L., Kruhoffer M., Thykjaer T., Marcussen N., Jensen J.L., Moller K., et al. Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 2004, 64:4040-4048.
27. Shariat S.F., Karakiewicz P.I., Palapattu G.S., Lotan Y., Rogers C.G., Amiel G.E., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006, 176:2414-2422. [discussion 22].
28. Stein J.P., Lieskovsky G., Cote R., Groshen S., Feng A.C., Boyd S., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001, 19:666-675.
29. Bassi P., Ferrante G.D., Piazza N., Spinadin R., Carando R., Pappagallo G., et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 1999, 161:1494-1497.
30. Ralhan R., He H.C., So A.K., Tripathi S.C., Kumar M., Hasan M.R., et al. Nuclear and cytoplasmic accumulation of Ep-ICD is frequently detected in human epithelial cancers. PLoS One 2010, 5:e14130.
31. Jachin S., Bae J.S., Sung J.J., Park H.S., Jang K.Y., Chung M.J., et al. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin. Int J Oncol 2014, 45:691-698.
32. Laubli H., Borsig L. Selectins promote tumor metastasis. Semin Cancer Biol 2010, 20:169-177.
33. Shen H., Wang X., Shao Z., Liu K., Xia X.Y., Zhang H.Z., et al. Alterations of high endothelial venules in primary and metastatic tumors are correlated with lymph node metastasis of oral and pharyngeal carcinoma. Cancer Biol Ther 2013, 15:342-349.
34. Sanchez-Carbayo M. Use of high-throughput DNA microarrays to identify biomarkers for bladder cancer. Clin Chem 2003, 49:23-31.